Found 13 matching trials
Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137) PHASE3 The aim of the study is to investigate the efficacy of ciclesonide versus b...
Show More Location
Altana Pharma/Nycomed
Learn More & Join Trial
Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206) PHASE3 The aim of the study is to compare the efficacy of ciclesonide versus fluti...
Show More Location
Altana Pharma/Nycomed
Learn More & Join Trial
Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129) PHASE3 The aim of the study is to investigate the effect of ciclesonide versus flu...
Show More Location
Altana Pharma/Nycomed
Learn More & Join Trial
Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101) PHASE3 The aim of the study is to compare the effect of ciclesonide on quality of ...
Show More Location
Altana Pharma/Nycomed
Learn More & Join Trial
Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136) PHASE3 This trial will compare the effectiveness of one dose of ciclesonide agains...
Show More Location
Altana Pharma/Nycomed
Learn More & Join Trial
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection PHASE2 Coverage Africa is a nested study in the large Anticov platform trial that ...
Show More Location
Centre Muraz/INSP
Learn More & Join Trial
Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis PHASE3 To demonstrate the effects of ciclesonide applied as a nasal aerosol and ci...
Show More Location
Clinical Research Atlanta
Learn More & Join Trial
Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma PHASE2 Exhaled breath condensate (EBC) has emerged as a novel noninvasive techniqu...
Show More Location
Department of Pediatrics and Allergy, Medical University of Lodz, Poland
Learn More & Join Trial
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older PHASE3 This is a 6-month multi-center, randomized, double-blind, placebo-controlle...
Show More Location
Asthma and Allergy Specialists Medical Group
Learn More & Join Trial
Effect of High Dose Ciclesonide on Asthma Control PHASE3 The aim of the trial is to investigate asthma control with 160 to 640 mcg c...
Show More Location
Multiple Locations
Learn More & Join Trial